D57.42
Sickle-cell thalassemia beta zero without crisis
Clinical Classification Guidelines
Inclusion Terms
- HbS-beta zero without crisis
- Sickle-cell beta zero without crisis
Medical Intelligence & Overview
Sickle-cell thalassemia beta zero without crisis is a genetic blood disorder characterized by the abnormal shape of red blood cells and a complete absence of hemoglobin beta chains. This condition typically causes fewer complications than sickle-cell crises but still requires careful management. It combines features of both sickle cell disease and thalassemia, leading to lifelong health monitoring and treatment needs.
Causes & Symptoms
Clinical Causes: T h i s c o n d i t i o n i s i n h e r i t e d a n d c a u s e d b y m u t a t i o n s i n t h e g e n e s r e s p o n s i b l e f o r h e m o g l o b i n p r o d u c t i o n . S p e c i f i c a l l y , i n d i v i d u a l s i n h e r i t t h e s i c k l e c e l l g e n e a n d t h e b e t a - z e r o t h a l a s s e m i a g e n e f r o m t h e i r p a r e n t s . T h e c o m b i n a t i o n l e a d s t o d e f e c t i v e h e m o g l o b i n m o l e c u l e s t h a t r e s u l t i n a b n o r m a l , s i c k l e - s h a p e d r e d b l o o d c e l l s , w h i c h a r e l e s s e f f i c i e n t a t t r a n s p o r t i n g o x y g e n a n d a r e f r a g i l e , l e a d i n g t o a n e m i a .
Key Symptoms: W h i l e t h e d i a g n o s i s i s l a b e l e d ' w i t h o u t c r i s i s , ' s o m e i n d i v i d u a l s m a y s t i l l e x p e r i e n c e s y m p t o m s , i n c l u d i n g : - C h r o n i c a n e m i a , c a u s i n g f a t i g u e a n d w e a k n e s s - J a u n d i c e o r y e l l o w i n g o f t h e s k i n a n d e y e s - S w e l l i n g i n t h e h a n d s a n d f e e t - D e l a y e d g r o w t h a n d d e v e l o p m e n t i n c h i l d r e n - I n c r e a s e d s u s c e p t i b i l i t y t o i n f e c t i o n s - M i l d e p i s o d e s o f p a i n d u e t o b l o o d v e s s e l b l o c k a g e s , a l t h o u g h n o t c l a s s i f i e d a s c r i s e s - B o n e p a i n o r d e f o r m i t i e s i n l o n g - t e r m c a s e s
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves blood tests to identify abnormal hemoglobin types: - Hemoglobin electrophoresis, which detects specific hemoglobin variants - Complete blood count (CBC) revealing anemia - Genetic testing to confirm inherited mutations Additional assessments may include ultrasound or MRI to evaluate organ health and monitor for potential complications.
Treatment Protocols: Management strategies focus on alleviating symptoms and preventing complications: - Regular health check-ups and blood tests - Blood transfusions in severe cases to manage anemia - Folic acid supplements to support red blood cell production - Antibiotics or vaccines to prevent infections - Pain management when necessary, even if not in crisis - Monitoring for organ damage over time - Emerging treatments like gene therapy are under research While there is no universal cure, these treatments aim to improve quality of life and reduce disease complications.
Clinical Advice & FAQs
Billing Guidance
Is D57.42 a billable ICD-10 code?
Yes, D57.42 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.42?
Clinical documentation must specify the nature of Sickle-cell thalassemia beta zero without crisis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference